Washington: Diabetes is a chronic condition that makes it difficult to regulate blood sugar levels. For many people, the condition worsens with time, making it harder to control blood sugar levels.
Semaglutide control blood sugar
Semaglutide is one example of a GLP-1 receptor agonist that has given patients more control over blood sugar lowering.
New information regarding new, higher-dose formulations of oral semaglutide has been provided by John Buse, MD, PhD, the Verne S. Caviness Distinguished Professor of Medicine in the Division of Endocrinology and Metabolism, and a global team of researchers.
